Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.

GPR40 has been reported to be activated by long-chain fatty acids, such as docosahexaenoic acid (DHA). However, reports studying functional role of GPR40 in the brain are lacking. The present study focused on the relationship between pain regulation and GPR40, investigating the functional roles of h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kazuo Nakamoto, Takashi Nishinaka, Naoya Sato, Mitsumasa Mankura, Yutaka Koyama, Fumiyo Kasuya, Shogo Tokuyama
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c7b84b5003f446ffb110bdf95fb9943c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c7b84b5003f446ffb110bdf95fb9943c
record_format dspace
spelling oai:doaj.org-article:c7b84b5003f446ffb110bdf95fb9943c2021-11-18T08:42:17ZHypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.1932-620310.1371/journal.pone.0081563https://doaj.org/article/c7b84b5003f446ffb110bdf95fb9943c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24349089/?tool=EBIhttps://doaj.org/toc/1932-6203GPR40 has been reported to be activated by long-chain fatty acids, such as docosahexaenoic acid (DHA). However, reports studying functional role of GPR40 in the brain are lacking. The present study focused on the relationship between pain regulation and GPR40, investigating the functional roles of hypothalamic GPR40 during chronic pain caused using a complete Freund's adjuvant (CFA)-induced inflammatory chronic pain mouse model. GPR40 protein expression in the hypothalamus was transiently increased at day 7, but not at days 1, 3 and 14, after CFA injection. GPR40 was co-localized with NeuN, a neuron marker, but not with glial fibrillary acidic protein (GFAP), an astrocyte marker. At day 1 after CFA injection, GFAP protein expression was markedly increased in the hypothalamus. These increases were significantly inhibited by the intracerebroventricular injection of flavopiridol (15 nmol), a cyclin-dependent kinase inhibitor, depending on the decreases in both the increment of GPR40 protein expression and the induction of mechanical allodynia and thermal hyperalgesia at day 7 after CFA injection. Furthermore, the level of DHA in the hypothalamus tissue was significantly increased in a flavopiridol reversible manner at day 1, but not at day 7, after CFA injection. The intracerebroventricular injection of DHA (50 µg) and GW9508 (1.0 µg), a GPR40-selective agonist, significantly reduced mechanical allodynia and thermal hyperalgesia at day 7, but not at day 1, after CFA injection. These effects were inhibited by intracerebroventricular pretreatment with GW1100 (10 µg), a GPR40 antagonist. The protein expression of GPR40 was colocalized with that of β-endorphin and proopiomelanocortin, and a single intracerebroventricular injection of GW9508 (1.0 µg) significantly increased the number of neurons double-stained for c-Fos and proopiomelanocortin in the arcuate nucleus of the hypothalamus. Our findings suggest that hypothalamic GPR40 activated by free long chain fatty acids might have an important role in this pain control system.Kazuo NakamotoTakashi NishinakaNaoya SatoMitsumasa MankuraYutaka KoyamaFumiyo KasuyaShogo TokuyamaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e81563 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kazuo Nakamoto
Takashi Nishinaka
Naoya Sato
Mitsumasa Mankura
Yutaka Koyama
Fumiyo Kasuya
Shogo Tokuyama
Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
description GPR40 has been reported to be activated by long-chain fatty acids, such as docosahexaenoic acid (DHA). However, reports studying functional role of GPR40 in the brain are lacking. The present study focused on the relationship between pain regulation and GPR40, investigating the functional roles of hypothalamic GPR40 during chronic pain caused using a complete Freund's adjuvant (CFA)-induced inflammatory chronic pain mouse model. GPR40 protein expression in the hypothalamus was transiently increased at day 7, but not at days 1, 3 and 14, after CFA injection. GPR40 was co-localized with NeuN, a neuron marker, but not with glial fibrillary acidic protein (GFAP), an astrocyte marker. At day 1 after CFA injection, GFAP protein expression was markedly increased in the hypothalamus. These increases were significantly inhibited by the intracerebroventricular injection of flavopiridol (15 nmol), a cyclin-dependent kinase inhibitor, depending on the decreases in both the increment of GPR40 protein expression and the induction of mechanical allodynia and thermal hyperalgesia at day 7 after CFA injection. Furthermore, the level of DHA in the hypothalamus tissue was significantly increased in a flavopiridol reversible manner at day 1, but not at day 7, after CFA injection. The intracerebroventricular injection of DHA (50 µg) and GW9508 (1.0 µg), a GPR40-selective agonist, significantly reduced mechanical allodynia and thermal hyperalgesia at day 7, but not at day 1, after CFA injection. These effects were inhibited by intracerebroventricular pretreatment with GW1100 (10 µg), a GPR40 antagonist. The protein expression of GPR40 was colocalized with that of β-endorphin and proopiomelanocortin, and a single intracerebroventricular injection of GW9508 (1.0 µg) significantly increased the number of neurons double-stained for c-Fos and proopiomelanocortin in the arcuate nucleus of the hypothalamus. Our findings suggest that hypothalamic GPR40 activated by free long chain fatty acids might have an important role in this pain control system.
format article
author Kazuo Nakamoto
Takashi Nishinaka
Naoya Sato
Mitsumasa Mankura
Yutaka Koyama
Fumiyo Kasuya
Shogo Tokuyama
author_facet Kazuo Nakamoto
Takashi Nishinaka
Naoya Sato
Mitsumasa Mankura
Yutaka Koyama
Fumiyo Kasuya
Shogo Tokuyama
author_sort Kazuo Nakamoto
title Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
title_short Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
title_full Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
title_fullStr Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
title_full_unstemmed Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
title_sort hypothalamic gpr40 signaling activated by free long chain fatty acids suppresses cfa-induced inflammatory chronic pain.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/c7b84b5003f446ffb110bdf95fb9943c
work_keys_str_mv AT kazuonakamoto hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT takashinishinaka hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT naoyasato hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT mitsumasamankura hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT yutakakoyama hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT fumiyokasuya hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
AT shogotokuyama hypothalamicgpr40signalingactivatedbyfreelongchainfattyacidssuppressescfainducedinflammatorychronicpain
_version_ 1718421468954492928